| Dr Steven M Tillem, MD | |
|
3119 Newtown Ave, Suite 801, Astoria, NY 11102-1350 | |
| (718) 777-2111 | |
| (718) 732-2191 |
| Full Name | Dr Steven M Tillem |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 32 Years |
| Location | 3119 Newtown Ave, Astoria, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235119090 | NPI | - | NPPES |
| 02057289 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 1982311 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Optum Medical Care Pc | 9931013240 | 997 |
News Archive
Coffee drinkers know that coffee helps keep the bowels moving, but researchers in Texas are trying to find out exactly why this is true, and it doesn't seem to be about the caffeine, according to a study presented at Digestive Disease Week® 2019.
Florida Atlantic University's Charles E. Schmidt College of Medicine has announced a $3 million gift to endow medical student scholarships. The endowment will be named the "Dr. Morton and Cynthia Levitt Endowed Scholarship for Medical Education," and the announcement was made during the Schmidt College of Medicine's inaugural "Your Medical School" celebration honoring Dick and Barbara Schmidt.
The University of Ottawa, the University of Montreal and the Assembly of First Nations are pleased to announce the newly published First Nations Food, Nutrition and Environment Study (FNFNES) in the Canadian Journal of Public Health.
Over the past decade, significant advances have been made in the treatment of leukemia through the ongoing development of gene-based targeted therapies. Research that will be presented today at the 52nd Annual Meeting of the American Society of Hematology provides greater understanding of the optimal use of several BCR-ABL inhibitors for the treatment of acute lymphoblastic leukemia and chronic myeloid leukemia, and how a new gene target functions for several myeloid malignancies.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
› Verified 3 days ago
| Entity Name | Optum Medical Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982643003 PECOS PAC ID: 9931013240 Enrollment ID: O20031119000321 |
News Archive
Coffee drinkers know that coffee helps keep the bowels moving, but researchers in Texas are trying to find out exactly why this is true, and it doesn't seem to be about the caffeine, according to a study presented at Digestive Disease Week® 2019.
Florida Atlantic University's Charles E. Schmidt College of Medicine has announced a $3 million gift to endow medical student scholarships. The endowment will be named the "Dr. Morton and Cynthia Levitt Endowed Scholarship for Medical Education," and the announcement was made during the Schmidt College of Medicine's inaugural "Your Medical School" celebration honoring Dick and Barbara Schmidt.
The University of Ottawa, the University of Montreal and the Assembly of First Nations are pleased to announce the newly published First Nations Food, Nutrition and Environment Study (FNFNES) in the Canadian Journal of Public Health.
Over the past decade, significant advances have been made in the treatment of leukemia through the ongoing development of gene-based targeted therapies. Research that will be presented today at the 52nd Annual Meeting of the American Society of Hematology provides greater understanding of the optimal use of several BCR-ABL inhibitors for the treatment of acute lymphoblastic leukemia and chronic myeloid leukemia, and how a new gene target functions for several myeloid malignancies.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
› Verified 3 days ago
| Entity Name | Prohealth Care Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275596280 PECOS PAC ID: 4486544186 Enrollment ID: O20040317000468 |
News Archive
Coffee drinkers know that coffee helps keep the bowels moving, but researchers in Texas are trying to find out exactly why this is true, and it doesn't seem to be about the caffeine, according to a study presented at Digestive Disease Week® 2019.
Florida Atlantic University's Charles E. Schmidt College of Medicine has announced a $3 million gift to endow medical student scholarships. The endowment will be named the "Dr. Morton and Cynthia Levitt Endowed Scholarship for Medical Education," and the announcement was made during the Schmidt College of Medicine's inaugural "Your Medical School" celebration honoring Dick and Barbara Schmidt.
The University of Ottawa, the University of Montreal and the Assembly of First Nations are pleased to announce the newly published First Nations Food, Nutrition and Environment Study (FNFNES) in the Canadian Journal of Public Health.
Over the past decade, significant advances have been made in the treatment of leukemia through the ongoing development of gene-based targeted therapies. Research that will be presented today at the 52nd Annual Meeting of the American Society of Hematology provides greater understanding of the optimal use of several BCR-ABL inhibitors for the treatment of acute lymphoblastic leukemia and chronic myeloid leukemia, and how a new gene target functions for several myeloid malignancies.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
› Verified 3 days ago
| Entity Name | Metropolitan Lithotriptor Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891027967 PECOS PAC ID: 5193615730 Enrollment ID: O20040317001512 |
News Archive
Coffee drinkers know that coffee helps keep the bowels moving, but researchers in Texas are trying to find out exactly why this is true, and it doesn't seem to be about the caffeine, according to a study presented at Digestive Disease Week® 2019.
Florida Atlantic University's Charles E. Schmidt College of Medicine has announced a $3 million gift to endow medical student scholarships. The endowment will be named the "Dr. Morton and Cynthia Levitt Endowed Scholarship for Medical Education," and the announcement was made during the Schmidt College of Medicine's inaugural "Your Medical School" celebration honoring Dick and Barbara Schmidt.
The University of Ottawa, the University of Montreal and the Assembly of First Nations are pleased to announce the newly published First Nations Food, Nutrition and Environment Study (FNFNES) in the Canadian Journal of Public Health.
Over the past decade, significant advances have been made in the treatment of leukemia through the ongoing development of gene-based targeted therapies. Research that will be presented today at the 52nd Annual Meeting of the American Society of Hematology provides greater understanding of the optimal use of several BCR-ABL inhibitors for the treatment of acute lymphoblastic leukemia and chronic myeloid leukemia, and how a new gene target functions for several myeloid malignancies.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
› Verified 3 days ago
| Entity Name | Newyork-presbyterian-queens |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013960962 PECOS PAC ID: 7315839933 Enrollment ID: O20040329000273 |
News Archive
Coffee drinkers know that coffee helps keep the bowels moving, but researchers in Texas are trying to find out exactly why this is true, and it doesn't seem to be about the caffeine, according to a study presented at Digestive Disease Week® 2019.
Florida Atlantic University's Charles E. Schmidt College of Medicine has announced a $3 million gift to endow medical student scholarships. The endowment will be named the "Dr. Morton and Cynthia Levitt Endowed Scholarship for Medical Education," and the announcement was made during the Schmidt College of Medicine's inaugural "Your Medical School" celebration honoring Dick and Barbara Schmidt.
The University of Ottawa, the University of Montreal and the Assembly of First Nations are pleased to announce the newly published First Nations Food, Nutrition and Environment Study (FNFNES) in the Canadian Journal of Public Health.
Over the past decade, significant advances have been made in the treatment of leukemia through the ongoing development of gene-based targeted therapies. Research that will be presented today at the 52nd Annual Meeting of the American Society of Hematology provides greater understanding of the optimal use of several BCR-ABL inhibitors for the treatment of acute lymphoblastic leukemia and chronic myeloid leukemia, and how a new gene target functions for several myeloid malignancies.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
› Verified 3 days ago
| Entity Name | New York Queens Medicine And Surgery, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003114851 PECOS PAC ID: 4082883673 Enrollment ID: O20110817000163 |
News Archive
Coffee drinkers know that coffee helps keep the bowels moving, but researchers in Texas are trying to find out exactly why this is true, and it doesn't seem to be about the caffeine, according to a study presented at Digestive Disease Week® 2019.
Florida Atlantic University's Charles E. Schmidt College of Medicine has announced a $3 million gift to endow medical student scholarships. The endowment will be named the "Dr. Morton and Cynthia Levitt Endowed Scholarship for Medical Education," and the announcement was made during the Schmidt College of Medicine's inaugural "Your Medical School" celebration honoring Dick and Barbara Schmidt.
The University of Ottawa, the University of Montreal and the Assembly of First Nations are pleased to announce the newly published First Nations Food, Nutrition and Environment Study (FNFNES) in the Canadian Journal of Public Health.
Over the past decade, significant advances have been made in the treatment of leukemia through the ongoing development of gene-based targeted therapies. Research that will be presented today at the 52nd Annual Meeting of the American Society of Hematology provides greater understanding of the optimal use of several BCR-ABL inhibitors for the treatment of acute lymphoblastic leukemia and chronic myeloid leukemia, and how a new gene target functions for several myeloid malignancies.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven M Tillem, MD 3119 Newtown Ave, Suite 801, Astoria, NY 11102-1350 Ph: (718) 777-2111 | Dr Steven M Tillem, MD 3119 Newtown Ave, Suite 801, Astoria, NY 11102-1350 Ph: (718) 777-2111 |
News Archive
Coffee drinkers know that coffee helps keep the bowels moving, but researchers in Texas are trying to find out exactly why this is true, and it doesn't seem to be about the caffeine, according to a study presented at Digestive Disease Week® 2019.
Florida Atlantic University's Charles E. Schmidt College of Medicine has announced a $3 million gift to endow medical student scholarships. The endowment will be named the "Dr. Morton and Cynthia Levitt Endowed Scholarship for Medical Education," and the announcement was made during the Schmidt College of Medicine's inaugural "Your Medical School" celebration honoring Dick and Barbara Schmidt.
The University of Ottawa, the University of Montreal and the Assembly of First Nations are pleased to announce the newly published First Nations Food, Nutrition and Environment Study (FNFNES) in the Canadian Journal of Public Health.
Over the past decade, significant advances have been made in the treatment of leukemia through the ongoing development of gene-based targeted therapies. Research that will be presented today at the 52nd Annual Meeting of the American Society of Hematology provides greater understanding of the optimal use of several BCR-ABL inhibitors for the treatment of acute lymphoblastic leukemia and chronic myeloid leukemia, and how a new gene target functions for several myeloid malignancies.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
› Verified 3 days ago
Dr. Nikhil Waingankar, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2510 30th Ave, #a5-316, Astoria, NY 11102 Phone: 718-808-7876 | |
Dr. Jeffrey J Sandhaus, M.D. Urology Medicare: Medicare Enrolled Practice Location: 3601 31st Ave, Astoria, NY 11106 Phone: 718-932-3535 Fax: 718-932-6939 |